The Canadian Supreme Court’s decision in the Harvard oncomouse case established that higher life forms are not patentable subject matter under Canadian law. While process claims were accepted, product claims for the transgenic mouse were rejected, setting a key precedent in biotechnology patents.
Read more about Patentability of Higher Life Forms